Well, we're really pleased. We think it's a very strong set of results. We saw revenue growth. We saw good profit growth, almost 10% profit growth on a constant currency basis, a continued expansion of our margins. So that revenue growth, coupled with very tight cost and expense controls, is what drove the double-digit profit improvement, and also the 34% improvement in earnings per share.

Well, there's plenty to go. We're really now trying to establish Misys' leadership position across the industries that we participate in. As you know, the merger with Allscripts went very, very well, and we really created the undisputed leader in that industry. Our Treasury and Capital Markets business has rebounded very strongly in the second half of the year, and clearly we're one of the leaders in the capital markets business. We've made a huge investment in our banking business, and we're beginning to see early signs that that business too will begin to turn around towards the end of this year, the early part of next year. So, until we become the leader in all of these industry segments, there's plenty of work to continue to do.

Yes, we think it's absolutely the right time. As I said, the merger was extremely successful. But as a result of the stimulus program, the market is beginning to change in the US, and hospitals in particular are becoming more and more important in the decision-making process as to what IT physicians will use. So we felt it was very important that Allscripts merge with Eclipsys, and be able to create this end-to-end platform between physicians all the way through to hospitals. In order to do that, we felt that it was time for Misys to sell down its control position, so that the capital structure could be freed up so Allscripts would continue to play its leadership role in the consolidation of that industry. And this was clearly a win for the Allscripts shareholders, for the Eclipsys shareholders, and the Misys shareholders. And there's very few times when you can bring that all together and create a win/win for customers, employees and investors, and we think that's exactly what we did. So, yes, we think it was absolutely the right time.

Well, it's progressing very well. The SEC has decided not to review the transaction. That's very good news. The period that Hart-Scott-Rodino can comment has expired, so we passed those two key regulatory hurdles. Later this week, we'll be mailing our circular to our shareholders. Allscripts has already done that. And we have a scheduled shareholder vote for the mid part of August.

We are really very, very comfortable with our Financial Services business. As I said our Treasury and Capital Markets business has returned to growth, and we are beginning to see some of those early signs in the Banking business. The Banking business has been in decline for the last year. This against a backdrop of uncertainty amongst banks, but some of that uncertainty is beginning to lift as we see more clarity around the regulatory environment that banks will participate in. So we feel comfortable that the macro environment is beginning to improve and should see that gain momentum as we exit this calendar year and move into the second-half of our fiscal year.

Well as I said we are beginning to see some early signs. So I wouldn't say it's a trend yet, but we are seeing, for example, improvement in our pipeline. So if we look out over the next six to eight months we see a lot of our new solutions beginning to build a substantial pipeline, things like BankFusion and Universal Banking and Mobile and Business Intelligence. Those are all early indicators that we are beginning to pick up some interest. The regulatory environment has clearly begun to change, and we have more clarity around the environment that banks can expect to participate in. So when you add that all up we are beginning to get a little more optimistic that we are going to see a return in bank spending as we exit this calendar year and we go into 2011.

We are continuing to invest in our product portfolio. So throughout this downturn over the last two or three years we have not only on an absolute basis increased our investment in R&D, but as a percent of that spend more and more of it is being spent towards new applications, new solutions and less money is being spent maintaining our old solutions. That's very encouraging.

Well I think its paying off now. We are seeing a substantial improvement in our Capital Markets business, some early signs that Banking is beginning to move in the right direct. And I think the most notable is customer satisfaction. Our customer satisfaction has improved dramatically over the last three years. And that's such an important metric, because our customers are telling us Misys you are getting better.

Well sure, as we complete the Allscripts transaction we said we are going to return around $1b to our shareholders. We will pay down some of the remaining net debt, because net debt is zero now as a Group, as a whole, which includes Allscripts. So post-Allscripts we will pay down some of the remaining debt, and that gives us the opportunity to continue to make investments in our product portfolio as well as our people that call on the customers. In addition, if good opportunities come along that would bolt into our overall framework for Capital Markets and Banking we would certainly consider that.

I expect us to take the next step. I expect to see our Banking business improve. I think our Capital Markets business will continue to do very well. And that really is the third phase of our turnaround program, which is to be the leader in these industries. And a leader sets the pace, a leader grows. A leader is able to deliver value to its customers. A leader has unique insights into how the technology, married with the people and processes, can add value to our clients. That's what a leader does. And that's the next step we are going to take over the next year or so is to become the leader in those industries.